The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation

BACKGROUND: KRAS mutation is the most common genetic alteration in lung adenocarcinoma (LADC) in Western countries and is associated with worse outcome in bone-metastatic cases. Yet, to date, no effective treatment guidelines were developed for these patients. Accordingly, our aim was to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Radeczky, Peter, Megyesfalvi, Zsolt, Laszlo, Viktoria, Fillinger, Janos, Moldvay, Judit, Raso, Erzsebet, Schlegl, Erzsebet, Barbai, Tamas, Timar, Jozsef, Renyi-Vamos, Ferenc, Dome, Balazs, Hegedus, Balazs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947398/
https://www.ncbi.nlm.nih.gov/pubmed/33718013
http://dx.doi.org/10.21037/tlcr-20-754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947398/
https://www.ncbi.nlm.nih.gov/pubmed/33718013
http://dx.doi.org/10.21037/tlcr-20-754

Ejemplares similares